SCHEMBL5579367

SCHEMBL5579367

O=C1NC(c2ccccc2)C(=O)Nc2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 7/20 0.59
PDGFRA P16234 1/20 0.48
FER P16591 1/20 0.48
LTK P29376 1/20 0.48
CDK8 P49336 1/20 0.48
ACVR1 Q04771 1/20 0.48
LRRK2 Q5S007 1/20 0.48
DYRK1B Q9Y463 1/20 0.48
MAPT P10636 3/20 0.45
GAA P10253 1/20 0.45
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 4/20 0.45
KMT2A Q03164 3/20 0.45
HSD17B10 Q99714 3/20 0.45
MEN1 O00255 2/20 0.45
MAPK1 P28482 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
TNKS O95271 2/20 0.43
PARP3 Q9Y6F1 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5579365 1.00 TNKS2 (0.59) TNKS2PDGFRAFERLTKCDK8
SCHEMBL2361451 0.82 KDM4E (0.57) TNKS2MAPTGAAALDH1A1KDM4E
SCHEMBL12749304 0.76 PBRM1 (0.41) TNKS2MAPTALDH1A1KDM4EKMT2A
SCHEMBL13802559 0.76 PBRM1 (0.51) MAPTALDH1A1KDM4EKMT2AHSD17B10
SCHEMBL13802554 0.76 PBRM1 (0.51) MAPTALDH1A1KDM4EKMT2AHSD17B10
SCHEMBL5075710 0.75 HDAC8 (0.45) TNKS2HSD17B10HPGDALOX15
SCHEMBL5579420 0.75 HDAC8 (0.45) TNKS2HSD17B10HPGDALOX15
SCHEMBL5079009 0.75 HDAC8 (0.45) TNKS2HSD17B10HPGDALOX15
SCHEMBL5063195 0.75 BRPF1 (0.67) TNKS2PDGFRAFERLTKCDK8
SCHEMBL30592979 0.75 BRPF1 (0.67) TNKS2PDGFRAFERLTKCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155730-A1 Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase METHYLGENE, INC. (CA) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155730-A1 Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase HDAC5, HDAC4, HDAC3 TNKS2 2488/4885PDGFRA 3029/4885FER 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.